Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1

Journal of Virological Methods

Volumn 189, Issue 2, 2013, Pages 375-378

  Fenard, David ^a,b,c   Genries, Sandrine ^a,b,c   Scherman, Daniel ^d,e,f   Galy, Anne ^a,b,c   Martin, Samia ^a   Kichler, Antoine ^a,d,e,f  

^a GÉNÉTHON   (France)

^b UMR S951 Généthon ^*  (France)

^c UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^d CNRS   (France)

^e Centre National de la Recherche Scientifique   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cationic amphipathic peptide; Gene therapy; Hematopoietic stem cell; Lentiviral vector

Indexed keywords

CD34 ANTIGEN; FIBRONECTIN; LAH4 L1; LENTIVIRUS VECTOR; PEPTIDE; RETRONECTIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOTYPING; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTACHMENT; VIRUS INFECTIVITY;

CELLS, CULTURED; FIBRONECTINS; HUMANS; LENTIVIRUS; PEPTIDES; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC; VIRUS ATTACHMENT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84876742477     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.02.005     Document Type: Article

References (13)

1. Barde I., Salmon P., Trono D. Production and titration of lentiviral vectors. Curr. Protoc. Neurosci. 2010, 53:4.21.1-4.21.23.
2. Charrier S., Dupre L., Scaramuzza S., Jeanson-Leh L., Blundell M.P., Danos O., Cattaneo F., Aiuti A., Eckenberg R., Thrasher A.J., Roncarolo M.G., Galy A. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Ther. 2007, 14:415-428.
3. Chien M.P., Lin C.H., Chang D.K. Recruitment of HIV-1 envelope occurs subsequent to lipid mixing: a fluorescence microscopic evidence. Retrovirology 2009, 6:20.
4. D'Costa J., Mansfield S.G., Humeau L.M. Lentiviral vectors in clinical trials: current status. Curr. Opin. Mol. Ther. 2009, 11:554-564.
5. Davis H.E., Rosinski M., Morgan J.R., Yarmush M.L. Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys. J. 2004, 86:1234-1242.
6. Gummuluru S., Rogel M., Stamatatos L., Emerman M. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J. Virol. 2003, 77:12865-12874.
7. Jacome A., Navarro S., Rio P., Yanez R.M., Gonzalez-Murillo A., Lozano M.L., Lamana M.L., Sevilla J., Olive T., Diaz-Heredia C., Badell I., Estella J., Madero L., Guenechea G., Casado J., Segovia J.C., Bueren J.A. Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients. Mol. Ther. 2009, 17:1083-1092.
8. Mason A.J., Gasnier C., Kichler A., Prevost G., Aunis D., Metz-Boutigue M.H., Bechinger B. Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH. Antimicrob. Agents Chemother. 2006, 50:3305-3311.
9. Mason A.J., Martinez A., Glaubitz C., Danos O., Kichler A., Bechinger B. The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes. FASEB J. 2006, 20:320-322.
10. Merten O.W., Charrier S., Laroudie N., Fauchille S., Dugue C., Jenny C., Audit M., Zanta-Boussif M.A., Chautard H., Radrizzani M., Vallanti G., Naldini L., Noguiez-Hellin P., Galy A. Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application. Hum. Gene Ther. 2011, 22:343-356.
11. Naldini L. Ex vivo gene transfer and correction for cell-based therapies. Nat. Rev. Genet. 2011, 12:301-315.
12. Pollok K.E., Williams D.A. Facilitation of retrovirus-mediated gene transfer into hematopoietic stem and progenitor cells and peripheral blood T-lymphocytes utilizing recombinant fibronectin fragments. Curr. Opin. Mol. Ther. 1999, 1:595-604.
13. Sandrin V., Boson B., Salmon P., Gay W., Negre D., Le Grand R., Trono D., Cosset F.L. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 2002, 100:823-832.